These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 35023789)
21. Changing presentation of complete hydatidiform mole at the New England Trophoblastic Disease Center over the past three decades: does early diagnosis alter risk for gestational trophoblastic neoplasia? Sun SY; Melamed A; Goldstein DP; Bernstein MR; Horowitz NS; Moron AF; Maestá I; Braga A; Berkowitz RS Gynecol Oncol; 2015 Jul; 138(1):46-9. PubMed ID: 25969351 [TBL] [Abstract][Full Text] [Related]
22. Gestational Trophoblastic Neoplasia From Genetically Confirmed Hydatidiform Moles: Prospective Observational Cohort Study. Usui H; Qu J; Sato A; Pan Z; Mitsuhashi A; Matsui H; Shozu M Int J Gynecol Cancer; 2018 Nov; 28(9):1772-1780. PubMed ID: 30358702 [TBL] [Abstract][Full Text] [Related]
23. Loss of Selenoprotein Iodothyronine Deiodinase 3 Expression Correlates with Progression of Complete Hydatidiform Mole to Gestational Trophoblastic Neoplasia. St Laurent JD; Lin LH; Owen DM; Maestá I; Castaneda A; Hasselblatt KT; Goldstein DP; Horowitz NS; Berkowitz RS; Elias KM Reprod Sci; 2021 Nov; 28(11):3200-3211. PubMed ID: 34129219 [TBL] [Abstract][Full Text] [Related]
24. Comparison between vacuum aspiration and forceps plus blunt curettage for the evacuation of complete hydatidiform moles. Sato A; Usui H; Shozu M Taiwan J Obstet Gynecol; 2019 Sep; 58(5):650-655. PubMed ID: 31542087 [TBL] [Abstract][Full Text] [Related]
25. Hormonal contraceptive use before hCG remission does not increase the risk of gestational trophoblastic neoplasia following complete hydatidiform mole: a historical database review. Braga A; Maestá I; Short D; Savage P; Harvey R; Seckl MJ BJOG; 2016 Jul; 123(8):1330-5. PubMed ID: 26444183 [TBL] [Abstract][Full Text] [Related]
26. Influence of COVID-19 pandemic on molar pregnancy and postmolar gestational trophoblastic neoplasia: An observational study. Campos V; Paiva G; Padron L; Freitas F; Pedrotti LG; Sun SY; Viggiano M; Oliveira L; Rohr L; Madi JM; Arrym TP; Oliveira P; Dos Santos Esteves APV; Junior JA; Filho JR; Elias KM; Horowitz NS; Braga A; Berkowitz RS BJOG; 2023 Feb; 130(3):292-302. PubMed ID: 36209485 [TBL] [Abstract][Full Text] [Related]
27. Expression of maspin in gestational trophoblastic disease. Li HW; Leung SW; Cheung AN; Yu MM; Chan LK; Wong YF Gynecol Oncol; 2006 Apr; 101(1):76-81. PubMed ID: 16271752 [TBL] [Abstract][Full Text] [Related]
28. Postmolar gestational trophoblastic neoplasia: beyond the traditional risk factors. Bakhtiyari M; Mirzamoradi M; Kimyaiee P; Aghaie A; Mansournia MA; Ashrafi-Vand S; Sarfjoo FS Fertil Steril; 2015 Sep; 104(3):649-54. PubMed ID: 26099850 [TBL] [Abstract][Full Text] [Related]
29. Expression patterns of ERVWE1/Syncytin-1 and other placentally expressed human endogenous retroviruses along the malignant transformation process of hydatidiform moles. Bolze PA; Patrier S; Cheynet V; Oriol G; Massardier J; Hajri T; Guillotte M; Bossus M; Sanlaville D; Golfier F; Mallet F Placenta; 2016 Mar; 39():116-24. PubMed ID: 26992684 [TBL] [Abstract][Full Text] [Related]
30. Expression of laminin receptor 1 in gestational trophoblastic diseases and normal placenta and its relationship with the development of postmolar tumors. Kurdoglu M; Bayram I; Kolusari A; Erten R; Adali E; Bulut G; Yildizhan R; Kurdoglu Z; Kucukaydin Z; Sahin HG Gynecol Oncol; 2009 Aug; 114(2):306-9. PubMed ID: 19481788 [TBL] [Abstract][Full Text] [Related]
31. Single-dose actinomycin D: Efficacy in the prophylaxis of postmolar gestational trophoblastic neoplasia in adolescents with high-risk hydatidiform mole. Uberti EM; Diestel MC; Guimarães FE; De Nápoli G; Schmid H Gynecol Oncol; 2006 Aug; 102(2):325-32. PubMed ID: 16476471 [TBL] [Abstract][Full Text] [Related]
32. [Expression and significance of LMP2 and PPM1A in gestational trophoblastic disease]. Zhang SS; Wan XY; Zhou CY; Lü WG; Xie X Zhonghua Fu Chan Ke Za Zhi; 2011 Jul; 46(7):510-5. PubMed ID: 22041443 [TBL] [Abstract][Full Text] [Related]
33. Does a human chorionic gonadotropin level of over 20,000 IU/L four weeks after uterine evacuation for complete hydatidiform mole constitute an indication for chemotherapy for gestational trophoblastic neoplasia? Braga A; Biscaro A; do Amaral Giordani JM; Viggiano M; Elias KM; Berkowitz RS; Seckl MJ Eur J Obstet Gynecol Reprod Biol; 2018 Apr; 223():50-55. PubMed ID: 29477553 [TBL] [Abstract][Full Text] [Related]
34. Assessment of Her-2/neu expression in hydatidiform moles for prediction of subsequent gestational trophoblastic neoplasia. Menczer J; Schreiber L; Berger E; Golan A; Levy T Gynecol Oncol; 2007 Mar; 104(3):675-9. PubMed ID: 17126893 [TBL] [Abstract][Full Text] [Related]
35. Uterine artery Doppler flow velocimetry parameters for predicting gestational trophoblastic neoplasia after complete hydatidiform mole, a prospective cohort study. Asmar FTC; Braga-Neto AR; de Rezende-Filho J; Villas-Boas JMS; Charry RC; Maesta I Clinics (Sao Paulo); 2017 May; 72(5):284-288. PubMed ID: 28591340 [TBL] [Abstract][Full Text] [Related]
36. Androgenetic Complete Hydatidiform Moles With p57KIP2-Positive Immunostaining. Usui H; Sato A; Ota M; Ikeda JI; Shozu M Am J Clin Pathol; 2020 Nov; 154(6):776-783. PubMed ID: 32686837 [TBL] [Abstract][Full Text] [Related]
37. Estrogen and progesterone receptors and telomerase enzyme immunohistochemical detection in gestational trophoblastic tumors. El-Shalakany AH; Kamel KM; Ismail AM; Salah L; El-Deen Fahmy SS; El-Deen Ammar E Int J Gynecol Cancer; 2006; 16(5):1918-26. PubMed ID: 17009992 [TBL] [Abstract][Full Text] [Related]
38. Prediction of Neoplastic Transformation of Hydatidiform Mole: Current Evidence. Laban M; El-Swaify ST; Refaat MA; Ibrahim EA; Abdelrahman RM Reprod Sci; 2021 Oct; 28(10):3010-3012. PubMed ID: 34341951 [TBL] [Abstract][Full Text] [Related]
39. Apoptotic index for prediction of postmolar gestational trophoblastic neoplasia. Braga A; Maestá I; Rocha Soares R; Elias KM; Custódio Domingues MA; Barbisan LF; Berkowitz RS Am J Obstet Gynecol; 2016 Sep; 215(3):336.e1-336.e12. PubMed ID: 27094961 [TBL] [Abstract][Full Text] [Related]
40. Effectiveness and toxicity of first-line methotrexate chemotherapy in low-risk postmolar gestational trophoblastic neoplasia: The New England Trophoblastic Disease Center experience. Maestá I; Nitecki R; Horowitz NS; Goldstein DP; de Freitas Segalla Moreira M; Elias KM; Berkowitz RS Gynecol Oncol; 2018 Jan; 148(1):161-167. PubMed ID: 29092742 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]